Marcello Tonelli Selected Research

Calcimimetic Agents

1/2020	Comparative Effectiveness of Calcimimetic Agents for Secondary Hyperparathyroidism in Adults: A Systematic Review and Network Meta-analysis.
1/2013	Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcello Tonelli Research Topics

Disease

67	Chronic Renal Insufficiency 04/2022 - 08/2002
57	Chronic Kidney Failure (Chronic Renal Failure) 12/2021 - 01/2002
35	Renal Insufficiency (Renal Failure) 01/2022 - 08/2002
28	Proteinuria 01/2022 - 06/2003
26	Kidney Diseases (Kidney Disease) 01/2022 - 06/2003
22	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 06/2003
21	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 08/2002
20	Myocardial Infarction 01/2020 - 01/2003
18	Albuminuria 01/2022 - 07/2006
15	Stroke (Strokes) 01/2021 - 01/2003
14	Hypertension (High Blood Pressure) 01/2020 - 09/2005
14	Anemia 01/2017 - 04/2005
13	Heart Failure 02/2021 - 03/2004
11	Coronary Disease (Coronary Heart Disease) 11/2019 - 01/2003
9	Neoplasms (Cancer) 04/2022 - 05/2009
8	Inflammation (Inflammations) 01/2021 - 07/2005
7	Infections 01/2021 - 04/2008
6	Chronic Disease (Chronic Diseases) 01/2021 - 01/2014
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2011
5	Obesity 01/2021 - 10/2011
5	Hemorrhage 01/2020 - 04/2007
5	Bacteremia 01/2018 - 04/2008
5	Fistula 12/2017 - 01/2008
4	Hyperkalemia 12/2021 - 04/2011
4	Thrombosis (Thrombus) 01/2020 - 01/2007
4	Ambulatory Care Sensitive Conditions 01/2019 - 11/2008
4	Diabetes Mellitus 02/2018 - 11/2004
4	Hyperphosphatemia 05/2017 - 10/2005
4	Malnutrition (Nutritional Deficiencies) 12/2015 - 09/2006
4	Acute Coronary Syndrome 07/2013 - 07/2005
4	Pathologic Constriction (Stenosis) 05/2012 - 11/2004
3	Hypotension (Low Blood Pressure) 02/2020 - 09/2002
3	Nausea 01/2020 - 01/2013
3	Cognitive Dysfunction 10/2019 - 12/2015
3	Transient Ischemic Attack 01/2019 - 06/2011
3	Hypercalcemia (Milk Alkali Syndrome) 11/2016 - 12/2009
3	Arteriovenous Fistula 08/2013 - 01/2005
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2011 - 10/2004
2	Dementia (Dementias) 04/2022 - 08/2017
2	Hypersensitivity (Allergy) 12/2021 - 01/2019
2	Asthma (Bronchial Asthma) 12/2021 - 01/2019
2	Noncommunicable Diseases 05/2021 - 03/2020
2	Body Weight (Weight, Body) 01/2021 - 07/2016
2	Hypocalcemia 01/2020 - 01/2013

Drug/Important Bio-Agent (IBA)

48	CreatinineIBA 01/2022 - 01/2003
20	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2003
18	AlbuminsIBA 01/2022 - 02/2010
15	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 08/2002
13	Hemoglobins (Hemoglobin)IBA 01/2018 - 05/2006
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2006
9	Angiotensin Receptor AntagonistsIBA 02/2020 - 08/2002
8	Phosphates (Orthophosphate)IBA 05/2017 - 10/2005
8	HematinicsIBA 01/2017 - 05/2009
7	CholesterolIBA 01/2014 - 01/2003
7	Pravastatin (Pravachol)FDA LinkGeneric 11/2006 - 01/2003
6	Pharmaceutical PreparationsIBA 01/2021 - 03/2007
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2006
5	LipidsIBA 06/2014 - 11/2004
5	MineralsIBA 09/2013 - 04/2005
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2005
4	HDL CholesterolIBA 01/2019 - 09/2004
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2018 - 10/2004
4	LDL CholesterolIBA 01/2018 - 09/2004
4	Sevelamer (RenaGel)FDA Link 11/2016 - 09/2004
4	oxidized low density lipoproteinIBA 07/2013 - 09/2006
3	Insulin (Novolin)FDA Link 01/2021 - 09/2006
3	Dialysis SolutionsIBA 01/2020 - 09/2006
3	Parathyroid Hormone (Parathormone)IBA 01/2020 - 01/2013
3	insulin receptor-related receptor (IRR)IBA 01/2020 - 05/2012
3	Alkaline PhosphataseIBA 11/2019 - 11/2009
3	Triglycerides (Triacylglycerol)IBA 01/2019 - 11/2004
3	Biological ProductsIBA 01/2019 - 07/2010
3	Phosphorus (Red Phosphorus)IBA 11/2016 - 11/2013
3	CalciumIBA 11/2016 - 05/2009
3	Epoetin Alfa (Epogen)FDA Link 12/2014 - 10/2004
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2010 - 10/2004
3	Vitamin D FDA LinkGeneric 11/2009 - 12/2007
3	Oxidoreductases (Dehydrogenase)IBA 06/2006 - 01/2003
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 07/2016
2	DiureticsIBA 01/2021 - 06/2006
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021 - 07/2016
2	SodiumIBA 01/2021 - 01/2014
2	AngiotensinsIBA 01/2020 - 08/2002
2	Cinacalcet (Sensipar)FDA Link 01/2020 - 01/2013

Therapy/Procedure

56	Renal Dialysis (Hemodialysis) 12/2021 - 09/2002
34	Therapeutics 01/2021 - 11/2002
20	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 09/2004
15	Kidney Transplantation 01/2022 - 11/2004
10	Catheters 01/2018 - 01/2005
6	Long-Term Care 01/2022 - 08/2017
6	Peritoneal Dialysis 05/2021 - 09/2006
5	Transplantation 05/2021 - 09/2007
4	Drug Therapy (Chemotherapy) 01/2021 - 10/2004
4	Length of Stay 01/2020 - 02/2008
4	Secondary Prevention 11/2019 - 01/2003
4	Central Venous Catheters 06/2017 - 09/2002
4	Ambulatory Care (Outpatient Care) 11/2016 - 11/2008
4	Glycemic Control 03/2013 - 05/2010
3	Blood Transfusion (Blood Transfusions) 12/2014 - 05/2009
3	Continuous Renal Replacement Therapy 07/2009 - 11/2002